Featured Publications
Decreasing alloimmunization‐specific mortality in sickle cell disease in the United States: Cost‐effectiveness of a shared transfusion resource
Ito S, Pandya A, Hauser R, Krishnamurti L, Stites E, Tormey C, Krumholz H, Hendrickson J, Goshua G. Decreasing alloimmunization‐specific mortality in sickle cell disease in the United States: Cost‐effectiveness of a shared transfusion resource. American Journal Of Hematology 2024, 99: 570-576. PMID: 38279581, DOI: 10.1002/ajh.27211.Peer-Reviewed Original ResearchSickle cell diseaseDelayed hemolytic transfusion reactionQuality-adjusted life expectancyAlloimmunized patientsPatient populationRed blood cell alloimmunizationCell diseaseCost-effective interventionMedical expenditure of patientsHealth system perspectiveExpenditure of patientsIncremental cost-effectiveness ratioHemolytic transfusion reactionsUnited StatesMarkov cohort simulationCost-effectiveAverage patient populationCost-effectiveness ratioBirth cohortAnalytical time horizonAntibody historyCohort simulationTransfusionTransfusion reactionsLife expectancy
2024
Sex, Lies, and Iron Deficiency in 2024: Cost-Effectiveness of Screening Ferritin Thresholds for the Treatment of Iron Deficiency in Women of Reproductive Age
Wang D, Glaeser-Khan S, Wang D, Moshashaian Asl R, Chetlapalli K, Ito S, Cuker A, Goshua G. Sex, Lies, and Iron Deficiency in 2024: Cost-Effectiveness of Screening Ferritin Thresholds for the Treatment of Iron Deficiency in Women of Reproductive Age. Blood 2024, 144: 277-277. DOI: 10.1182/blood-2024-203654.Peer-Reviewed Original ResearchIncremental cost-effectiveness ratioFerritin thresholdIron deficiencyCost-effectiveness ratioIron supplementationNational Health and Nutrition Examination Survey dataUS Medical Expenditure Panel SurveyNutrition Examination Survey dataMedical Expenditure Panel SurveyAverage annual healthcare costsHealth-related well-beingWillingness-to-pay (WTP) thresholdAbsence of universal screeningAnnual healthcare costsWell-being of affected individualsAdult womenStudies of iron statusCost-effective interventionID diagnosisIron dextranTreated with iron supplementationTreatment of iron deficiencyHematologic follow-upOral ferrous sulfateIntravenous iron dextran